2024
Case report: Tremor in the placebo condition of a blinded clinical trial of intermittent theta-burst stimulation for cocaine use disorder
Steele V, Rotenberg A, Philip N, Hallett M, Stein E, Salmeron B. Case report: Tremor in the placebo condition of a blinded clinical trial of intermittent theta-burst stimulation for cocaine use disorder. Frontiers In Psychiatry 2024, 15: 1391771. PMID: 39045554, PMCID: PMC11263940, DOI: 10.3389/fpsyt.2024.1391771.Peer-Reviewed Original ResearchCocaine use disorderIntermittent theta burst stimulationTheta burst stimulationPlacebo responseUse disorderClinically relevant effectsBlind clinical trialClinical responseNew-onsetPlacebo conditionClinical trialsSham iTBSFunctional disordersPersistent tremorBurst stimulationCocaineDisordersShamStimulationTrialsWeak E-fieldsRelevant effectsTremorStimulating the posterior parietal cortex reduces self-reported risk-taking propensity in people with tobacco use disorder
LoFaro F, Jordan T, Apostol M, Steele V, Konova A, Petersen N. Stimulating the posterior parietal cortex reduces self-reported risk-taking propensity in people with tobacco use disorder. Addiction Neuroscience 2024, 12: 100160. PMID: 39329155, PMCID: PMC11426420, DOI: 10.1016/j.addicn.2024.100160.Peer-Reviewed Original ResearchPosterior parietal cortexTobacco use disorderRisk-taking propensityUse disorderWithin-session changesRisk behaviorsParietal cortexSingle-sessionRisk-takingBenefits of risk-takingDisordersVisual cortexCortexComprehensive measureSample participantsNeuromodulation protocolsDlPFCPerceptionBehaviorTobaccoParticipantsPropensityTherapeutic indicationsIndividualsFindingsParameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity
Network A, Sangchooli A, Zare-Bidoky M, Jouzdani A, Schacht J, Bjork J, Claus E, Prisciandaro J, Wilson S, Wüstenberg T, Potvin S, Ahmadi P, Bach P, Baldacchino A, Beck A, Brady K, Brewer J, Childress A, Courtney K, Ebrahimi M, Filbey F, Garavan H, Ghahremani D, Goldstein R, Goudriaan A, Grodin E, Hanlon C, Haugg A, Heilig M, Heinz A, Holczer A, Van Holst R, Joseph J, Juliano A, Kaufman M, Kiefer F, Zonoozi A, Kuplicki R, Leyton M, London E, Mackey S, McClernon F, Mellick W, Morley K, Noori H, Oghabian M, Oliver J, Owens M, Paulus M, Perini I, Rafei P, Ray L, Sinha R, Smolka M, Soleimani G, Spanagel R, Steele V, Tapert S, Vollstädt-Klein S, Wetherill R, Witkiewitz K, Yuan K, Zhang X, Verdejo-Garcia A, Potenza M, Janes A, Kober H, Zilverstand A, Ekhtiari H. Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity. JAMA Psychiatry 2024, 81: 414-425. PMID: 38324323, PMCID: PMC11304510, DOI: 10.1001/jamapsychiatry.2023.5483.Peer-Reviewed Original ResearchTreatment developmentNeurobiology of drug addictionDrug cue reactivitySubstance use disordersBiomarkers of addictionCue reactivityAddictive disordersBiomarker developmentDrug addictionTreatment responseTreatment outcomesVisual cuesTask designCore aspectsAddictionClinical judgmentParticipant characteristicsDisordersOutcome predictorsClinical useMEDLINE databaseBiomarker qualificationSeveral biomarkersTranslational gapDatabase inception
2022
Characterizing Impulsivity in Individuals with Heroin Use Disorder
Kang T, Zhang Y, Zhao J, Li X, Jiang H, Niu X, Xie R, Ding X, Steele V, Yuan T. Characterizing Impulsivity in Individuals with Heroin Use Disorder. International Journal Of Mental Health And Addiction 2022, 22: 1530-1545. DOI: 10.1007/s11469-022-00941-8.Peer-Reviewed Original ResearchHeroin use disorderHealthy controlsUse disordersClinical severityMale healthy controlsSubstance use disordersDaily dosageRehabilitation hospitalFormer groupBIS-11 scoresMale participantsDisordersMale individualsSeverityParticipantsImpulsivityScoresTotal net scoreCognitive impulsivityGroupHospitalIGTIndividualsHow an Exemplar of Chronic Neuromodulation for Cocaine Use Disorder is a Path Forward for Treating Substance Use Disorders
Steele V. How an Exemplar of Chronic Neuromodulation for Cocaine Use Disorder is a Path Forward for Treating Substance Use Disorders. Biological Psychiatry 2022, 91: s37. DOI: 10.1016/j.biopsych.2022.02.110.Peer-Reviewed Original Research
2019
Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead
Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, Castelo-Branco L, Challet-Bouju G, Clark VP, Claus E, Dannon PN, Del Felice A, den Uyl T, Diana M, di Giannantonio M, Fedota JR, Fitzgerald P, Gallimberti L, Grall-Bronnec M, Herremans SC, Herrmann MJ, Jamil A, Khedr E, Kouimtsidis C, Kozak K, Krupitsky E, Lamm C, Lechner WV, Madeo G, Malmir N, Martinotti G, McDonald W, Montemitro C, Nakamura-Palacios EM, Nasehi M, Noël X, Nosratabadi M, Paulus M, Pettorruso M, Pradhan B, Praharaj SK, Rafferty H, Sahlem G, Salmeron BJ, Sauvaget A, Schluter RS, Sergiou C, Shahbabaie A, Sheffer C, Spagnolo PA, Steele VR, Yuan TF, van Dongen J, Van Waes V, Venkatasubramanian G, Verdejo-García A, Verveer I, Welsh J, Wesley MJ, Witkiewitz K, Yavari F, Zarrindast MR, Zawertailo L, Zhang X, Cha YH, George TP, Frohlich F, Goudriaan AE, Fecteau S, Daughters SB, Stein EA, Fregni F, Nitsche MA, Zangen A, Bikson M, Hanlon CA. Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead. Neuroscience & Biobehavioral Reviews 2019, 104: 118-140. PMID: 31271802, PMCID: PMC7293143, DOI: 10.1016/j.neubiorev.2019.06.007.Peer-Reviewed Original ResearchConceptsSubstance use disordersNon-invasive brain stimulationConsensus paperAddiction medicineNovel treatment optionsMental health disordersTranscranial magnetic stimulationRecent FDA approvalHeterogeneity of methodsNIBS treatmentTreatment optionsFuture therapiesMagnetic stimulationBrain stimulationPreclinical neuroscienceClinical practiceHealth disordersFDA approvalNeural circuitsNeuromodulation toolBasic neuroscienceSUD researchStimulationSystematic literature reviewDisorders